- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, May 30, 2025
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from the San Francisco Examiner referenced a study published in the February 2022 issue of The American Journal of Managed Care® (AJMC®). The study, “Value-Based Care Through Postacute Home Health Under CMS PACT Regulations,” found that the PACT policy could be lowering readmissions and reducing total expenditures in patients without a need of postacute care.
An article from Home Health Care News highlighted a commentary published in a supplemental issue of AJMC. The commentary, “The Role of Managed Care Professionals in Improving Care for Patients With ALS,” discussed the role of gene therapy in potentially treating amyotrophic lateral sclerosis (ALS) as well as the challenges of its cost.
An opinion piece from The Times-Gazette referenced an article published on AJMC.com, the website of AJMC. The article, “US Health Care System Ranks Last Overall Among Other High-Income Countries,” covered results from a report showing that the US health care system ranked last on equity, access to care, and outcome measures compared with 10 other high-income countries.
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
